[
    [
        {
            "time": "2023-07-20",
            "original_text": "格隆汇A股公告精选(7.20) | 长城汽车上半年归母净利润预降近六成 多家公司股东抛出大额减持计划",
            "features": {
                "keywords": [
                    "长城汽车",
                    "归母净利润",
                    "预降",
                    "六成",
                    "减持",
                    "大额"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "格隆汇A股公告精选(7.20) | 长城汽车上半年归母净利润预降近六成 多家公司股东抛出大额减持计划",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-20",
            "original_text": "凯莱英：拟定增募资不超23亿元，投资3个项目及补血",
            "features": {
                "keywords": [
                    "凯莱英",
                    "定增",
                    "募资",
                    "23亿元",
                    "投资项目",
                    "补血"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英：拟定增募资不超23亿元，投资3个项目及补血",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-20",
            "original_text": "凯莱英(002821.SZ)拟定增募资不超23亿元 用于创新药CDMO项目及一站式服务平台扩建项目等",
            "features": {
                "keywords": [
                    "凯莱英",
                    "定增",
                    "募资",
                    "23亿元",
                    "创新药",
                    "CDMO",
                    "一站式服务",
                    "扩建"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)拟定增募资不超23亿元 用于创新药CDMO项目及一站式服务平台扩建项目等",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]